Navigating Use of Immunotherapy in mNSCLC
Specialists discuss adverse reactions to immunotherapy and explore the importance of CTLA-4 inhibitors in mNSCLC treatment.
Source: ajmc.com
Poseidon Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Poseidon Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Poseidon Trial Today - Breaking & Trending Today
Advancements in NSCLC Profiling and Understanding Immunotherapy Resistance
Experts examine primary and acquired resistance mechanisms in immunotherapy, while promoting realistic treatment strategies.
Source: ajmc.com
Optimizing the Selection of Novel Therapy for Patients With Advanced NSCLC
Closing out their panel on immunotherapy in non–small cell lung cancer, expert oncologists share key takeaways on the selection of novel therapy in this setting.
Source: onclive.com
Advanced NSCLC: Interpreting Data From the POSEIDON Trial
A brief review of the POSEIDON trial, which analyzed durvalumab with or without tremelimumab in combination with chemotherapy in advanced NSCLC.
Source: onclive.com
Role for IO Therapy in Advanced NSCLC With Concomitant KRAS and KEAP1/STK11 Mutations
Key opinion leaders in the field of non–small cell lung cancer management discuss the role of immunotherapy in patients with concomitant KRAS and KEAP1/STK11 mutations.
Source: onclive.com